In landmark trial, experimental drug delays type 1 diabetes Unlisted Video

In the culmination of a 33-year quest, scientists are reporting a milestone in type 1 diabetes: the first time the disease has been markedly delayed in young people at high risk. According to Science Magazine, California researchers found that 2 weeks of an experimental intravenous drug held off disease by an average of about two years. The mainstay of type 1 diabetes treatment is insulin, discovered 97 years ago.